Abstract. Double subgenomic Sindbis (dsSIN) viruses were engineered to transduce mosquito cells with antisense RNA derived either from the premembrane (prM) or polymerase (NS5) coding regions of the 17D vaccine strain of yellow fever virus (YFV). Aedes albopictus C6/36 cells were infected at high multiplicities of infection (MOI) with each dsSIN virus. Forty-eight hours later, the transduced cells were challenged with an MOI of 0.1 of the Asibi strain of YFV. At 72-hr postchallenge, the cells were assayed by immunofluorescence for the presence of YFV antigen. Cells transduced with prM or NS5 antisense RNAs derived from the YFV genome displayed no YFV-specific antigens. In contrast, cells infected with control dsSIN viruses that expressed no antisense RNA or dengue virus-derived antisense RNAs were permissive for the challenge virus. To analyze resistance in the mosquito, five log 10 50% tissue culture infective doses (TCID 50 ) of each dsSIN virus and three log 10 TCID 50 of either a West African (BA-55) or South American (1899/81) strain of wild-type YFV were coinoculated into Ae. aegypti. Mosquitoes transduced with effector RNAs targeting the prM or NS5 gene regions did not transmit West African YFV and poorly transmitted the South American strain of YFV.
The availability of an effective vaccine has been instrumental in the control of YF; however, there is a growing concern that the demands for the vaccine may overtake production. 5 Additionally, the collapse of effective Ae. aegypti control in the Americas during the 1970s has significantly increased the risk of urban YFV transmission. With reduced vector control, insecticide resistance, increased urbanization, global travel, and environmental changes, the number of cases of mosquito-borne diseases such as YF will increase. New disease control strategies are now being considered that include the spread of anti-pathogen genes into vector populations that can profoundly alter disease transmission. [6] [7] [8] [9] The identification of anti-pathogen genes that interrupt disease transmission by vectors such as Ae. aegypti is a significant first step in realizing this control strategy.
Viral transducing systems derived from the mosquitoborne alphavirus, Sindbis (SIN; Togaviridae), are particularly useful for rapidly identifying gene-based strategies that prevent pathogen replication in the vector and alter disease transmission. The use of double subgenomic (dsSIN) transducing viruses to express genes in mosquito cells has been reviewed. 7, 10, 11 The dsSIN viruses allow efficient, transient gene expression in vertebrate cells and long-term, stable, cytoplasmic expression in invertebrate cells. The TE/3Ј2J dsSIN viruses generated from infectious cDNA clones of the SIN virus RNA genome contain a second subgenomic promoter between the end of the structural protein coding region and the viral 3Ј non-coding region. In addition to expression of the genomic and subgenomic mRNAs, cells infected with recombinant dsSIN viruses produce a second subgenomic mRNA from which heterologous protein may be translated. In recent publications, we have shown that dsSIN viruses can efficiently transduce mosquito cells with complementary RNAs to the nucleocapsid mRNA of La Crosse (LAC) virus (Bunyaviridae) or premembrane (prM) coding region of dengue type 2 virus (DEN-2). [12] [13] [14] [15] These effector RNAs establish pathogen-derived resistance (PDR) in the mosquito cell to the superinfecting virus.
The viral genome of YFV is a single-stranded, positivesense RNA (11 kb) . The genomic RNA is translated as a single polyprotein (350 kD), which is cleaved co-and posttranslationally by both host cell and virus-encoded proteases to generate three structural and seven nonstructural proteins arranged in the order 5Ј capsid-premembrane (prM)-envelope (E)-nonstructural (NS) 1-NS2A-NS2B-NS3-NS4A-NS4B-NS5 3Ј. The functions of the 10 viral proteins have been reviewed. 16, 17 In this study, we have engineered two dsSIN viruses that transduce mosquito cells with antisense RNAs that are complementary to the prM and NS5 coding regions. We have tested the efficacy of these antisense RNAs to target different regions of the RNA genome of YFV and ablate YFV replication in mosquito cells. Additionally, we demonstrated that expression of the same antisense effector RNA can establish PDR in mosquito cells to both a West African and a South American strain of YFV and significantly alter transmission of these viruses by Ae. aegypti.
MATERIALS AND METHODS

Cells and viruses.
The YFV strains (Asibi; BA-55; 1899/ 81) were obtained from the Centers for Disease Control and FIGURE 1. Plasmid map of the parent double subgenomic Sindbis (dsSIN) virus construct pTE/3Ј2J. A 774-basepair (bp) cDNA that contained the yellow fever virus (YFV) premembrane (prM) and a 1,009 bp cDNA of the polymerase (NS5) sequence were cloned into the Xba I site in the antisense orientation, producing two plasmids designated dsSIN.yf/prMa and dsSIN.yf/GDDa. Prevention (CDC, Fort Collins, CO). The Asibi strain (passage 195) originated from a human case in Ghana in 1927; 18 the BA-55 strain (passage 3) was isolated from a human case in Nigeria in 1986; 19 the 1899/81 strain (passage 5) was isolated from a human patient in Peru in 1981. 20 The YFV strains were propagated in C6/36 (Ae. albopictus) cells in Liebovitz (L-15) medium at 28ЊC. Baby hamster kidney (BHK-21) and C6/36 cells were subcultured in Leibovitz L-15 medium supplemented with 10% fetal calf serum (FBS), 10% tryptose phosphate broth, and 100 units of penicillin/100 mg of streptomycin/ml, and maintained in L-15 medium containing 2% FBS.
Engineering of dsSIN constructs. The construction of dsSIN plasmids TE/3Ј2J, TE/3Ј2J/CAT, and D2prMa have been described previously. 14, 21, 22 The YFprM forward (5Ј-ATGGTGGCCAGTTTGATGAGAGGAT-3Ј) and reverse (5Ј-TCAACACACTTTCCTCACCTCAGCA-3Ј) primers were used to amplify by the polymerase chain reaction (PCR) a 774-base pair (bp) cDNA from YFV-17D cDNA clone CL1921/FLYF-4 that contained the full-length prM coding region. A 1009-bp region that spanned the part of the NS5 gene including the GDD motif, 23 was PCR-amplified from pCL1921/FLYF-4 using forward (5Ј-ATGGA-TGGTGGTGGATTCTAC-3Ј) and reverse (5Ј-TCA-AGGTGGCCCTATTGGTCAT-3Ј) primers with Taq polymerase (Promega, Madison, WI). The 5Ј ends of the forward and reverse primers contained start and stop codons, respectively. The PCR products were inserted into pBluescript II KS plasmid (Stratagene, La Jolla, CA) with a modified Nhe I site by TA cloning at an Eco RV site. 24 Each insert was excised with Nhe I and Xba I restriction endonucleases and ligated downstream of the second subgenomic promoter into the Xba I site of the dsSIN plasmid pTE/3Ј2J. Orientation was determined by restriction enzyme digestion and agarose gel electrophoresis. Plasmids that contained the 774-bp and 1,009-bp sequences in the antisense orientation were designated pyf/prMa and pyf/GDDa, respectively ( Figure 1) .
Analysis of RNA. Total cellular RNA was isolated from infected cells by guanidinium thiocyanate extraction. 25 Approximately 10 g of total RNA was analyzed by Northern hybridization. 26 An oligonucleotide probe (5Ј-GCTGGTCGG ATCATTGGGGCG-3Ј) complementary to the dsSIN 3Ј noncoding region was end labeled using ␥-32 P-labeled ATP (Amersham Corp., Arlington Heights, IL) with T4 polynucleotide kinase (Promega). The probe containing 3 ϫ 10 5 cpm/ml of radioisotope was hybridized at 60ЊC for 4 hr. The hybridization solution contained 10% dextran sulfate, 1% sodium dodecyl sulfate, 4.8% (w/v) sodium chloride, and 200 mg/ml of denatured salmon sperm DNA. The Nytran Plus membrane (Schleicher and Schuell, Inc., Keene, NH) was exposed to Fuji RX x-ray film (Fuji Photo Film Co., Ltd., Tokyo, Japan) for 4 hr. Double subgenomic Sindbis virus production. Virus production has been described. 27 Briefly, the dsSIN DNA templates were linearized at the Xho I site and transcribed in vitro from the bacteriophage SP6 promoter. 13, 21, 28 A 7-methyl-guanidine triphosphate capping analog (Ambion, Inc., Austin, TX) was added to each transcription reaction at a concentration of 1.0 mM. The RNA products were electroporated (BTX, Inc., San Diego, CA) into BHK-21 cells at 500 V, 100 mF, and 720 ohms for a duration of approximately 0.8 msec. The cells from each electroporation reaction were immediately seeded into 25-cm 2 cell culture flasks with 10 ml of L-15 medium containing 10% FBS and in- cubated at 37ЊC for 30-48 hr. The dsSIN viruses were harvested from the medium and titrated in BHK-21 cells using an end-point assay. 27, 29 Antibodies. Monoclonal antibodies (MAbs) to SIN E1 protein (MAb 30.11a) and to YFV envelope (E) protein (MAb 813) were produced as described previously.
30, 31
Interference with YFV replication in C6/36 cells. Immunofluorescence assays (IFAs) were used to assess interference qualitatively. The C6/36 cells were grown to confluence on sterile 18-mm diameter glass coverslips in 12-well tissue culture plates (Corning Costar Corp., Cambridge, MA). Cells were infected with dsSIN viruses at an MOI of 10 for 1 hr at 28ЊC and then 1.0 ml of L-15 medium with 10% FBS was added. At 48-hr, postinfection sample coverslips were examined by immunofluorescence 32 using MAb 30.11a. When all cells were infected with dsSIN and expressing heterologous protein, they were challenged with YFV (Asibi) at an MOI of 0.1. From previous experiments we knew this MOI would produce patent YFV infections with high levels of antigen expression. At 72-hr postchallenge, coverslips were washed in phosphate-buffered saline, fixed in cold acetone and examined for YFV E protein using MAb 813.
Mosquitoes. Aedes aegypti mosquitoes originating from Rexville, Puerto Rico were obtained from Dr. B. Miller (CDC, Fort Collins, CO) and were reared at 28ЊC, 80% relative humidity, and with a photocycle of 16L:8D. 33 Mosquito infections. Approximately, five log 10 50% tissue culture infective doses (TCID 50 ) of each dsSIN virus and three log 10 TCID 50 of either a West African (BA-55) or South American (1899/81) strain of wild-type YFV were intrathoracically coinoculated into Ae. aegypti mosquitoes. 34 Each respective virus dose alone was sufficient to infect mosquitoes. The higher titer coupled with the relatively rapid replication of alphaviruses ensured that most tissues (fat body, nervous system, and salivary glands) would be infected with dsSIN virus prior to dissemination of the simultaneously inoculated YFV. 35 Although inoculating the viruses meant that midgut cells would not be efficiently infected, it ensured that 100% of mosquitoes were infected. 12, 15 Following inoculation of 0.5 l of virus, mosquitoes were held for 14 days at 28ЊC and 80% relative humidity.
Collection and analysis of saliva to determine transmission rates. At 14 days postinfection, mosquitoes were chilled and legs and wings were removed. The proboscis was inserted into 10-l capacity capillary tubes (Fisher Scientific, Pittsburgh, PA) containing Cargille type B immersion oil (R. P. Cargille Laboratories, Inc., Cedar Grove, NJ) for 3 hr at room temperature. The mosquitoes were removed and frozen at Ϫ70ЊC for IFA of heads to determine infection rates. Oilcontaining saliva was mixed with 10 l of L-15 medium containing 2% SIN virus-neutralizing antibody and centrifuged at 10,000 ϫ g to separate oil and aqueous layers. 12, 15 The aqueous mixture was incubated at 4ЊC for 1 hr and 0.5-l aliquots were inoculated into groups (n ϭ 5-10) of recipient Ae. aegypti mosquitoes. The recipient mosquitoes were maintained at 28ЊC for seven days and heads were examined by IFA for YFV E antigen. Transmission of YFV was considered to have occurred if E antigen was detected in any group of recipient mosquitoes.
RESULTS
Double subgenomic Sindbis viruses.
Five dsSIN viruses, TE/3Ј2J, TE/3Ј2J/CAT, D2prMa, dsSIN.yf/prMa, and ds-SIN.yf/GDDa were generated by electroporating BHK-21 cells with RNA transcribed in vitro from linearized dsSIN virus template DNA. Twenty-four hours later virus was harvested from the medium and an aliquot was titrated in BHK-21 cells. The titers of the dsSIN viruses ranged from 7.5 to 9.0 log 10 TCID 50 /ml.
Analysis of RNA. The C6/36 cells were infected with the dsSIN viruses at an MOI of 10 and incubated at 28ЊC for 48 hr. Northern blot analysis of total RNA from C6/36 cells infected with TE/3Ј2J virus showed three intracellular mRNA species. The genomic mRNA (G) was detected at approximately 13 kb, the first subgenomic RNA (S1) at 4.5 kb and the second subgenomic RNA (S2) at 0.7 kb. The size of G, S1, and S2 mRNAs in cells infected with the other dsSIN viruses were larger than TE/3Ј2J RNAs by the size of the inserted sequence (Figure 2) . Interference in vitro. The C6/36 cells on glass coverslips were infected at an MOI of 10 with TE/3Ј2J, D2prMa, dsSIN.yf/prMa, or dsSIN.yf/GDDa virus. At 48 hr postinfection, some of the coverslips were analyzed by immunofluorescence and all cells displayed SIN virus E1 antigen, ensuring that 100% of the cells were infected with the dsSIN viruses. Cells on the remaining coverslips were then challenged with an MOI of 0.1 of the Asibi strain of YFV. At 72 hr postchallenge, the cells were assayed for the presence of YFV envelope antigen. The C6/36 cells that were infected with TE/3Ј2J or D2prMa viruses prior to challenge supported YFV replication as determined by the abundance of cellassociated YFV envelope antigen ( Figure 3C and E). In contrast, cells infected with dsSIN.yf/prMa or dsSIN.yf/GDDa viruses prior to challenge were completely resistant to YFV replication ( Figure 3D and F) . The C6/36 cells infected with the Asibi strain only displayed YFV E antigen ( Figure 3A ) and uninfected C6/36 cells were negative by IFA ( Figure  3B) .
Interference with YFV infection in vivo. Groups of 50-100 mosquitoes were coinjected with 5.0 log 10 TCID 50 of each dsSIN virus and 3.0 log 10 TCID 50 of either a West African (BA-55) or South American (1899/81) strain of YFV. Fourteen days later the heads of selected mosquitoes from each group were analyzed by IFA for the presence of YFV E antigen. The head of an injected mosquito was considered positive for YFV infection if fluorescence of the E antigen was detected throughout the head tissues. One hundred percent of the mosquitoes injected with only YFV BA-55 or 1899/81 virus displayed YFV E antigen in their heads (Table  1) . Additionally, 100% of the mosquitoes coinjected with the West African or South American YFV and either TE/3Ј2J, TE/3Ј2J/CAT or D2prMa virus were positive for YFV E antigen (Table 1 ). In contrast, none of the heads of mosquitoes coinjected with YFV BA-55 virus and either dsSIN.yf/prMa or dsSIN.yf/GDDa virus were positive for infection ( Table  1) . One of nine heads of mosquitoes coinjected with YFV (1899/81) and dsSIN.yf/prMa virus was positive for YFV E antigen; the heads of two of nine mosquitoes coinjected with the dsSIN.yf/GDDa virus and the South American YFV also were positive (Table 1) . We dissected the salivary glands from one mosquito from each group coinjected with YFV 1899/81 virus and either L-15 medium, TE/3Ј2J, dsSIN.yf/ prMa, or dsSIN.yf/GDDa virus and analyzed the tissue for the presence of YFV E antigen. While salivary glands from mosquitoes injected with YFV 1899/81 virus and either L-15 medium or TE/3Ј2J virus were positive for YFV infection, the mosquitoes injected with YFV 1899/81 virus and dsSIN.yf/prMa or dsSIN.yf/GDDa virus were clearly negative for YFV infection (Figure 4) .
Interference with transmission of YFV.
To analyze the ability of the transduced mosquitoes to transmit YFV, mosquito saliva was collected from each group of coinjected mosquitoes. Saliva from each mosquito was then injected into at least five recipient mosquitoes and seven days later the heads of these mosquitoes were analyzed for the presence of YFV E antigen. If even one of the mosquitoes from each group of recipient mosquitoes showed fluorescence for YFV E antigen throughout the head tissue, the saliva was considered positive for YFV transmission. The IFA of heads of recipient mosquitoes injected with saliva from mosquitoes coinjected with YFV 1899/81 virus and either L-15 medium, TE/3Ј2J, dsSIN.yfprMa, or dsSIN.yfGDDa virus is shown in Figure 5 . The contrast in YFV E antigen fluorescence was marked between recipient mosquitoes that were transduced with an effector RNA ( Figure 5C and D) and mosquitoes lacking an effector RNA ( Figure 5A and B) . Sixty to 100% of salivas from mosquitoes coinjected with YF BA-55 or 1899/81 virus and either L-15 medium, TE/3Ј2J, TE/3Ј2J/ CAT, or D2prMa control virus were positive for YFV transmission. None of the recipient mosquitoes injected with saliva from mosquitoes that had been coinjected with YF BA-55 virus and either dsSIN.yf/prMa or dsSIN.yf/GDDa virus were infected with YFV, indicating that the transduced mosquitoes were incapable of transmitting the West African strain of YFV (Table 1) . One (12.5%) of eight salivas from mosquitoes that had been coinjected with YF 1899/81 virus and dsSIN.yfprMa virus transmitted the South American strain of YFV, one (11%) of nine salivas from mosquitoes transduced with dsSIN.yf/GDDa virus transmitted YFV 1899/81 (Table 1) .
DISCUSSION
The target sites for antisense RNA inhibition of YFV were selected for two reasons. First, the target site that included the prM coding region was selected because it is located near the 5Ј end of the YFV genome and antisense inhibition of translation would affect synthesis of the eight proteins downstream of prM; we also have found that effector RNAs complementary to the prM gene of the dengue type 2 virus were very efficient at interfering with the replication of that virus. 14, 15 Second, antisense RNA was targeted to a region of the NS5 gene that encoded the GDD motif, the conserved active site of polymerization in all RNA-dependent RNA polymerases of positive strand RNA viruses. 16, 17, 23, 36 This strategy would allow us to assess the ability of an effector RNA that is complementary to a site near the 3Ј end of the genome to establish RNA-mediated resistance to YFV in the mosquito.
The mechanism of antisense RNA inhibition of viral replication is not known. Several hypotheses have been proposed to explain intracellular RNA-mediated resistance to virus replication. 1) The expressed antisense RNA binds to viral genomic mRNAs, thereby preventing ribosome attachment and/or elongation during translation. 2) Binding of the antisense RNA to the viral RNA facilitates degradation of the RNA duplexes by specific ribonucleases, effectively reducing the amount of mRNA that can be translated and/or preventing viral genomic RNA replication.
3) The antisense RNA binds to the sense genomic RNA, preventing binding or elongation by the viral polymerase during negative strand synthesis. 37, 38 These mechanisms are not mutually exclusive, and all may play a role in the inhibition of YFV viral replication by antisense RNA.
Virus-specific, RNA-mediated interference may be an important strategy for engineering mosquitoes that are incompetent for transmitting RNA virus such as YFV. However, extensive natural genetic variation in the target sequence of the virus genome could reduce the effectiveness of the effector RNA. The RNA viruses have had extraordinary evolutionary success and exist in nature as a mixture of subpopulations with related but different (more or less fit) genomes (quasispecies). 39, 40 The primary source for variation in RNA viruses is point mutations. 40, 41 No proofreading exo- nucleases are associated with RNA-dependent RNA polymerases, so the error rate is between 10 Ϫ3 and 10 Ϫ4 per nucleotide per replication cycle. 42 The presence of a strong selection pressure such as that imposed by PDR strategies could select novel virus genomes that escape the interference strategy. However, the rapid evolution of RNA viruses such as YFV is tempered because of their need to alternate between vertebrate and insect hosts. Arboviruses must possess genotypic traits that allow fitness in two different microenvironments. This feature is believed to place constraints on the number of arboviral RNA genome subpopulations that are fit to replicate in the two different microenvironments. 43, 44 It is clear that the efficiency of RNA-mediated interference is dependent on high sequence identity between the effector and target RNAs. 12, 14, 45 Powers and others 12 demonstrated that when mosquito cells are transduced with a 984-base antisense RNA derived from the small segment RNA of LAC virus, the cells were highly resistant to infection with LAC, snowshoe hare (SSH) and Tahyna (TAH) viruses. The transduced cells were not resistant to trivittatus (TVT) virus infection. The SSH and TAH viruses small segment RNAs share 87 and 81% sequence identity, respectively, with LAC virus small segment RNA. In contrast, TVT and LAC viruses share only 71% sequence identity in this genome segment. Additionally, effector RNAs derived from the prM coding region of dengue type 2 (Jamaica 1409) virus genome readily established PDR in mosquito cells to dengue type 2 viruses (Thailand 16681); however, the effector RNA did not interfere with dengue type 3 or 4 viruses because of high sequence divergence at the prM locus among the virus serotypes. 14, 15 The prM coding region of DEN-2 1409 virus shares 93.78% of its nucleotide sequence with the prM sequence of DEN-2 16681 virus, but less than 70% of its prM sequence with the DEN-3 or DEN-4 viruses. 14, 46, 47 The 774-nucleotide target sequence that included the prM coding region of six West African, two Central/East African, and eight New World strains of YFV has been compared with the complement of the antisense RNA derived from the 17D YFV genome to assess how much genetic variation naturally occurs at the target site (Table 2) . These sequence comparisons show that all four West African YFV isolates share approximately 90-100% identity with the 17D sequence. The two Central/East African and nine New World YFV strains share 77-78% and 84.11-87.60%, respectively, of their sequences with the 17D sequence. The ability of the effector RNAs to efficiently ablate the infection and transmission of West African BA-55 YFV is best explained by the origin of 17D vaccine strain of YFV. This attenuated virus was derived from the West African Asibi strain of YFV. 51 Sequence analysis of cDNA from several regions of the genome of a number of YFV isolates has shown that there are four distinct genotypes of YFV: the West African, Central/East African, and two South American genotypes. 19, 50, 52 More analyses of the abilities of field isolates of YFV from Africa and the Americas to escape interference are underway. These analyses may identify effector RNA sequences which are even more efficacious at interfering with the replication and transmission of YFV from Africa and the Americas.
We have shown that effector RNAs that target the prM and NS5 coding regions of YFV are very effective at restricting YFV replication in mosquito cells and transmission by transduced mosquitoes. It may be possible to construct a single antisense RNA that contains two consensus sequences, one that is complementary to the prM target sites of the West African YFV isolates and the other that is complementary to the NS5 target sequences of YFV isolates from the Americas. A comparison of six YFV prM sequences from viruses isolated at various geographic regions in the Americas with the prM sequence of YFV 1899/81 shows that the shared sequence identity is greater than 88% (Table 2 ). This sequence information shows that by choosing the proper sequences, we could design a PDR strategy in which an antisense RNA has two consensus sequences, each approximately 500 bases in length and each having greater than 90% sequence identity to its respective target sequence. We theorize that the target sequence of any virus selected by this strategy will have to diverge an additional 5-10% in its sequence to escape interference. We are currently designing new effector RNAs that will efficiently target and inhibit replication of New World, West African, and Central/East African strains of YFV.
Molecular genetic approaches that disrupt the transmission cycle of the pathogen may be important disease control strategies of the future. Although the efficacy of RNA-mediated PDR is dependent on the degree of sequence identity between the target RNA and the complement of the effector RNA, we were able to identify two effector RNAs that efficiently reduced transmission of YFV strains from two continents. The dsSIN viruses are important tools for expressing antiviral agents in mosquitoes and have led to the identification of potentially important strategies for profoundly altering pathogen transmission by mosquitoes. A critical next step is to express the effector RNAs from DNA-based tran-scriptional units that are stably integrated into the chromosomes of mosquito cells. The dsSIN viruses may offer important clues as to the level of antisense RNA expression required to knock out virus replication and how to traffic the effector RNAs to cellular compartments where flaviviruses replicate.
